StockData
Olema Oncology, Inc. logo

Olema Oncology, Inc. (OLMA) stock

OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$7.02−0.13 (-1.82%)

Close on Nov 20, 2026Market cap $614.23MP/E –Yield –

Olema Oncology gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Olema Oncology

Olema Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Olema Oncology figures

See a number that looks wrong?